Closed
SectorHealthcare
3 -7.69
24h
Min
2.95
Max
3.25
Income | 5M -79M |
---|---|
Sales | 15M 74M |
EPS | -0.26 |
Profit margin | -106.602 |
Employees | 838 |
EBITDA | 14M -75M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +510.15% upside |
Next Earnings | 8 maj 2025 |
---|
Market Cap | -524M 1.2B |
---|---|
Previous open | 10.69 |
Previous close | 3 |
By Acuity
50%
50%
167 / 386 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 19.83 USD 510.15%
High 32 USD
Low 6 USD
Based on 13 Wall Street analysts offering 12 month price targets forIovance Biotherapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$